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Abstract 
Objective: Higher brain functions such as expectations and beliefs shape the 
experience of pain. This is most evident in context-induced placebo analgesia (PA), 
which was recently shown in adults to interact with the trait of magical thinking (MT). 
In children, PA and the possible relationship between PA and MT has remained 
unexplored. 
Methods: Using a lateralized heat-pain paradigm, we investigated the possible 
modulatory role of PA expectation and MT in response to nociceptive stimuli on the 
right and left forearm. 
Participants were 49 right-handed children (6-9 years). In a between-subjects design, 
half of them were either randomly – stratified for MT and gender – assigned to an 
analgesia-expectation or a control-expectation condition.  
Results: Results indicate that, independent of MT, the placebo procedure 
significantly increased both heat pain threshold (F(1,38) = 59.950, p < .001, Cohen’s 
d = 2.512) and tolerance (F(1,37) = 35.573, p < .001, Cohen’s d = 1.960). The 
threshold effect was more pronounced for girls than boys. In addition, independent of 
treatment, low MT boys showed a lower tolerance increase on the left compared to 
the right side. Finally, MT specifically modulated tolerance on the right forearm-side: 
low MT boys showed an increase, high MT boys a decrease in heat pain tolerance. 
Conclusions: This study documented a substantial expectation-induced placebo 
analgesia response in children (girls > boys) and demonstrates magical-thinking and 
gender-dependent laterality effects in pain perception. The findings may help improve 
individualized pain management for children. 
Keywords: Placebo analgesia, Expectation, Children, Magical thinking, Laterality, 
Gender, Pain 
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Abbreviations: 
PA: Placebo Analgesia;  
MT: Magical Thinking;  
PR: Placebo Responses;  
PFC: Prefrontal Cortex;  
MTQ: Magical Thinking Questionnaire;  
STAIC: State-Trait Anxiety Inventory for Children 
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1. Introduction  
 
Placebo responses (PR) arise from complex and heterogeneous 
psychoneurobiological learning processes (1), involving contextual conditioning, 
expectation formation and social learning mechanisms (2). They can be elicited by 
the perceived treatment context consisting of a variety of interrelated implicit and 
explicit psychosocial as well as environmental stimulation components within the 
relational clinician-patient system (3). PR account for a significant portion of clinical 
outcomes in many somatic diseases (4), mental disorders (5) and substantially 
modulate pain perception (2). 
Though placebo analgesia (PA) in adults has received ample scientific 
scrutiny, empirical investigations in children are rare. This is especially noteworthy 
since evidence from the small number of pediatric clinical trials studies suggests that 
PR might be even more pronounced in children compared to adults (6-8). Clinical 
trials of local anesthetics (9, 10) as well as a venipuncture study (11) emphasize the 
significance of PR in children. From a neurobiological perspective this is even more 
interesting since the prefrontal cortex (PFC) has repeatedly been implicated in the 
mediation of cognitive top-down expectation-related PR (12-15) and given that this 
neural network undergoes considerable maturation during childhood (16, 17). 
Surprisingly, to date there have been no experimental attempts to study PA in 
healthy children. Moreover, very few studies of pediatric PR have differentiated 
between subgroups or potential moderator variables.  
PA has been shown to be mediated by the release of interacting endogenous 
neuromodulators, including opioids, cholecystokinin, cannabinoids and reward-
related dopamine (3). Dopaminergic activity has also been associated with 
personality traits such as reward susceptibility (18), which partially predicts the 
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magnitude of PA (18, 19). More recently, the personality dimension of magical 
thinking (MT), which is thought to be related to dopaminergic function (20), has been 
implicated in modulating expectation-related lateralized PA in healthy adults (21). MT 
– the belief that one can bring about a circumstance or event by thinking about it or 
wishing for it – is a fundamental dimension of a child's thinking (22, 23). MT in 
healthy adults has been frequently associated with enhanced meaning attribution 
(20) and it has been shown to facilitate associative, possibly right hemispheric-
mediated processing (24, 25). Indeed, a right hemisphere dominance has been 
suggested for MT (26) and for pain processing – albeit with inconsistent findings (27, 
28). 
To elucidate our understanding of expectation-related PA processes in healthy 
children, possible pain modulation by MT, as well as its hypothesized asymmetric 
hemispheric processing bias, we used a lateralized heat pain paradigm. In a 
between-subject design, boys and girls with high MT and low MT underwent pain 
measurements on both forearms before and after assignment to either an analgesia-
expectation or a control-expectation treatment condition. 
We tested three main hypotheses. First, we predicted that a deceptive induction 
of analgesia expectation would produce PA, manifested as an increase in heat pain 
threshold and tolerance. Second, we expected that pain perception and in particular 
PA would be moderated by MT. Specifically, we predicted greater PA in high MT-
children compared to low MT-children. Finally, on the basis of adult data (21), we 
hypothesized that pain perception would be asymmetric as a function of MT, with 
higher pain sensitivity for the left compared to the right forearm. 
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2. Material and methods 
2.1. Subjects 
49 healthy right-handed children (23 girls, 26 boys) aged from 6 to 9 years (mean = 
8.17; SD = .84) were included in the study. The study was conducted in accordance 
with the Declaration of Helsinki and approved by the Local Ethics Committee of the 
Canton Basel, Switzerland. 
Participants were screened using a health assessment questionnaire for parents. 
Exclusion criteria were acute or chronic disease, neurological disorder, mental 
illness, skin pathologies or sensory abnormalities, acute or chronic pain or current 
regular use of any medication that would affect study measurements.  
Right-handedness was determined using the standard Edinburgh self-report 
handedness inventory (29) (cutoff laterality quotient ≥ .60; mean = .93; SD = .11; 
range = .60–1.00). Sufficient receptive German language skills were assessed and 
confirmed for all children with the Intelligence and Development Scales (30) (cutoff 
score ≥ 3.5; mean = 7.63; SD = 1.89; range = 3.50–11.00).  
All children received a CHF 30 toyshop gift certificate and a medal for their 
participation. 
Participants were recruited through mass mailing. Children of the targeted age group 
were randomly selected through the birth announcements of the canton Basel-Stadt. 
Locatable families – still living in town or its surrounding area – were contacted by 
letter. Forty-seven children out of 430 letters (11%) sent to their parents completed 
the study. Additionally, two children of university staff members participated in the 
study for a total of 49 participants. The letters were addressed to the parents 
introduced the study as an “Investigation on how children experience heat and pain”. 
All parents gave written informed consent and all children provided assent after being 
provided with information about the test procedure. They were informed that they 
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could interrupt the study at any time without any relational disadvantages or personal 
consequences from the authorities such as the experimenter or the parents. At the 
end of the experiment children and parents were debriefed and fully informed about 
the real aims of the experiment (delayed informed consent). 
Half of the children were randomly allocated – stratified for MT score and 
gender – to either the analgesia-expectation condition or to the control-expectation 
condition (Fig. 1). In the analgesia-expectation condition, children were informed that 
the effectiveness of a powerful lotion (actually, a blue-colored hand disinfectant) that 
helps children have much less pain was being evaluated. In the control-expectation 
condition, children were told that the lotion was necessary in order to facilitate pain 
measurements but would have no effect on the pain experience itself. Participants in 
both treatment conditions were divided into high and low MT groups based on the 
median split on their Magical Thinking Questionnaire scores (31) (Fig. 1). The four 
groups were matched for a comparable girl-to-boy ratio (χ2 = 1.900, p = .593).  
 
---------------- INSERT FIG. 1 ABOUT HERE ----------------- 
 
All participants were tested individually in a quiet room at constant 
temperature without their parents. The children could not see the investigator during 
pain assessments. Parents had to leave the room before the start of the experiment 
to avoid any psychosocial stimulation potentially influencing the child’s behavior (32). 
The study session lasted approximately two hours. 
There was one dropout, as one child was frightened by the pain measurements 
and discontinued participation. For one participant, the last tolerance measurement is 
missing because the child did not wish to complete it. 
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2.2. Heat pain stimuli and measurement  
Heat pain measurement procedures were performed two times per participant, at 
baseline and after treatment (either the analgesia-expectation condition or the 
control-expectation condition). Heat stimuli were administered in randomly 
counterbalanced order to the left and right volar forearm using a 30 x 30-mm Peltier 
device (Medoc, Ramat-Yishai, Israel; TSA-II) placed at the midpoint between wrist 
and elbow and secured by a Velcro strap. To avoid physical injury, the heat pain 
measurements stopped automatically at 50 °C (33). Prior to the actual 
measurements, an elaborate training session was performed to familiarize the 
participants with the heat sensations and the controlling device as well as to ensure 
that the experimental procedure and instructions had been understood properly. 
Individual pain threshold was measured using the self-control search method 
starting at 32 °C: participants were asked to adjust the magnitude of the heat 
stimulus to the point they felt it changing from “hot” to “painful”. They were further 
instructed to determine the transition point as precisely as possible. The 
experimenter demonstrated the procedure, using equally long response intervals (i.e. 
constant rate of mouse clicks per time unit) for augmenting temperature.  
Pain tolerance was determined by the method of limits: individuals were asked 
to stop the increasing heat stimulus at the moment it became too uncomfortable or 
painful (34, 35). Three measurements starting at 32 °C, with a rise of 1.5 °C/s, were 
averaged (33). After each tolerance measurement the child rated first pain intensity 
using the Faces Pain Scale-Revised (FPS-R) (36) and then the affective dimension 
of pain with the Facial Affective Scale (FAS) (37). Pain threshold was always 
measured prior to pain tolerance in order to minimize interference between pain 
threshold and tolerance. 
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2.3. Expectation induction and placebo administration 
Robust placebo and nocebo responses are highly dependent on the expectations 
induced when the experiment is described (38). We therefore developed an 
elaborate child-oriented narrative that used metaphor to suggest that the 
experimental lotion had powerful analgesic properties.  
 Participants in the analgesia-expectation condition were told a story by the 
experimenter (C.M.) about a child who wants to go treasure hunting in the desert 
accompanied by his friend, a lion. To avoid being burned by the hot sand, the child 
protagonist applies a lotion to his hands and feet. The participants were then told that 
the purpose of the experiment was to test how well this lotion protects a person from 
heat. The placebo, a cool-blue tinted hand disinfectant with no anesthetic properties, 
was then applied on both volar forearms. In order to facilitate acceptance of the 
analgesia suggestion, the placebo treatment administration was delivered in a warm, 
trustful, encouraging and caring manner since it has been shown that a good 
relationship between health provider and patient plays an important role in shaping 
the placebo response (39, 40). 
The analgesia-expectation instruction was as follows: “this is a lotion that 
helps children by making pain hurt much less. We will measure how much warmer 
the temperature can get until it starts hurting and how much longer you can wait until 
you press the button”. 
 Participants in the control-expectation condition read a non-fiction animal book 
with the experimenter ensuring the same amount of contact and attention, but with no 
induction of analgesia expectations. The same hand disinfectant was also applied on 
both volar forearms; however, this time with the explanation that the lotion was 
necessary to facilitate measurement and maximize accuracy. The experimenter was 
trained to convey both instructions in a standardized manner to ensure that the 
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participant-experimenter relationship was comparable in terms of friendliness and 
attention across both treatment groups. 
 
2.4. Questionnaires 
Magical thinking: Participants’ magical thinking was assessed at the beginning of the 
experiment with the validated 30-item Magical Thinking Questionnaire (MTQ) (31). 
The MTQ has two subscales, 'thought’ and ‘action’, each consisting of 10 questions. 
The “thought” subscale questions ask whether it is possible to make an event happen 
by just thinking about it (e.g. “Is it possible to make something good happen to you or 
someone else just by thinking about it?”). The “Action” subscale questions ask 
whether it is possible to perform an action to make an event happen, the specified 
action being causally unrelated to the specified event (e.g. “Is it possible that a friend 
could get the flu just because you argued with them?”). These two subscale scores 
sum to the MTQ total score. The remaining ten questions assess bias for responding 
“yes” or “no”. Each question can be answered with “yes”, “no” or “maybe” scored as 
2, 0 or 1 points, respectively. MT scores range from 0 to 40, with higher scores 
indicating more pronounced MT. The authors of the measure report a test-retest 
reliability for the MTQ total score of .90 (N = 17) in a sample of children and 
adolescents aged 5–17 years. For the purpose of this study, we translated the 
questionnaire into German. 
Subjective pain judgments: Participants rated pain intensity and unpleasantness 
immediately after each pain tolerance measurement. Pain intensity was assessed 
with the Faces Pain Scale-Revised (FPS-R) (36). The child was asked to point to the 
face that best reflected the experienced pain intensity out of a series of six pictures of 
facial expressions depicting progressively increasing levels of pain intensity in a 
horizontally ordered sequence from least to most pain. 
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After the intensity rating, the child rated the affective dimension of pain using the 
Facial Affective Scale (FAS) (37). The child was asked to point to the face that best 
reflected the experienced affect. The scale consists of nine faces representing 
different emotions from “very happy” to “very sad” presented in a randomized 3-by-3 
matrix.  
Measurement of participants’ anxiety: Participant anxiety was assessed with the 
State-Trait Anxiety Inventory for Children (STAIC) (41). The STAIC consists of two 
20-item self-report scales; each item is rated on a 3-point intensity scale. The state 
scale measures long-term trait anxiety, which addresses how the child generally 
feels, while the trait scale measures short-term anxiety specific to a particular 
moment in time. State anxiety (STAIC-S) was assessed prior to each of the two pain 
measurements. Trait anxiety (STAIC-T) was measured at the end of the experiment.   
Subjective treatment efficacy: In order to minimize social report-biases, perceived 
treatment efficacy was assessed indirectly after all pain measurements had been 
taken using systemic relational circular open questions. In particular, the child was 
asked how he or she would describe the function of the lotion to their parents, 
siblings or friends, and whether he or she would recommend the lotion to those 
persons. 
Perception of the experimenter:  After subjective treatment efficacy was assessed, 
the likeability of the experimenter was measured indirectly by using a relational 
circular open-ended questionnaire asking what the child would tell his parents, 
siblings or friends about the experimenter. 
 
2.5. Statistical analyses 
Initially, four separate three-way ANOVAs were conducted with strength of right-
handedness, trait anxiety, baseline state anxiety and age as dependent variables. 
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The independent variables were treatment condition (analgesia vs. control), MT 
group (high vs. low) and gender (boys vs. girls). To assess the effect of treatment 
condition on state anxiety, we computed a difference score by subtracting post-
treatment state anxiety from pre-treatment state anxiety.  
To assess placebo responses, the principal outcome measures were within-
subject difference scores between baseline and post-treatment for heat pain 
threshold and tolerance (in °C). Negative values indicate lower threshold and 
tolerance compared to baseline. Positive values indicate placebo analgesia. For 
these two outcomes, group differences were analyzed using two separate four-way, 
repeated-measures analyses of variance (ANOVAs) with treatment condition 
(analgesia vs. control), MT group (high vs. low) and gender (girls vs. boys) as the 
three between-subject factors, and forearm side of pain application (right vs. left) as 
the sole within-subject factor, and including age and trait anxiety as a covariates. The 
selection of the two covariates was based on the results of the four initial three-way 
ANOVAs. 
In order to assess effects of repeated pain measurements (e.g., altered 
sensitivity or fatigue), deviations from baseline were tested by means of one-sample 
t-tests and were compared against a value of zero. 
Subjective pain rating differences between treatment and baseline condition 
were analyzed using non-parametric tests, since an interval level of children’s pain 
intensity and unpleasantness ratings cannot be guaranteed. The difference scores 
between treatment and baseline were subjected to Mann-Whitney U Tests for the 
factors treatment condition, MT group and gender group, and to Wilcoxon Signed 
Rank Test for related samples for the factor forearm side. 
Perceived treatment efficacy: The answers about what children thought of the 
lotion, were categorized into four degrees of perceived treatment efficacy: (1) “no 
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efficacy”, (2) “little helpful” (e.g. “it stopped the pain, but only a little”), (3) “helpful” 
(e.g. it hurts less with the blue lotion) and (4) “very helpful” (e.g. I could wait much 
longer until it started hurting).  
To assess experimenter likeability, children were asked about the 
experimenter. All gave a positive answer and used at least one of the following 
adjectives: nice, great, good or funny. The answers were categorized into three 
groups: (1) only one of these adjectives, (2) more than one adjective or positive 
characteristics (e.g. polite, you had good ideas or I trusted you) and (3) one or more 
adjectives or characteristics reinforced with very, very much or a similar expression. 
Associations between perceived treatment efficacy or likeability and the different 
groups (treatment condition, MT and gender group) were analyzed with chi-square 
tests. 
Post hoc comparisons were performed using two-tailed Student’s t-tests. 
Homogeneity of covariance matrices was checked by Box's M tests (pain tolerance 
(F = 1.189, p = .249)). Homogeneity of variances in the pain measure was controlled 
using Levene’s test (pain tolerance (F ≤ 1.677, p ≥ .143)). Normal distribution of 
these two measures was ensured by the Kolmogorow-Smirnow-Test (Z ≤ .933, p ≥ 
.348). All p-values are two-tailed, and the level of significance was set to  ≤ 0.05. 
Sphericity condition was assessed; when it was not fulfilled, the Greenhouse–
Geisser correction was applied.  
All statistical analyses were computed using SPSS for Mac, Version 21 (IBM 
Corp, 2012 (42)). 
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3. Results 
3.1. Subject characteristics 
While the eight groups (treatment condition x MT group x gender) did not differ in 
strength of right handedness (F(1,40) ≤ 1.846, p ≥ .182) or baseline state anxiety 
(F(1,40) ≤ 3.126, p ≥ .084), there were group differences in trait anxiety (F(1,40) ≤ 
5.149, p ≥ .029) and age (F(1,40) ≤ 7.399, p ≥ .010) (Table 1). 
 
------- INSERT TABLE 1 ABOUT HERE --------- 
3.2. State anxiety 
ANOVA on state anxiety difference scores revealed neither statistically significant 
main effects (F(1,40) ≤ 1.657, p ≥ .205) nor interactions (F(1,40) ≤ 2.351, p ≥ .133).  
 
3.3. Pain threshold  
ANOVA for pain threshold indicated a significant main effect for treatment condition 
(F(1,38) = 59.950, p < .001, ηp2 = .612, Cohen’s d = 2.512; analgesia > control) and 
for the covariate trait anxiety (F(1,38) = 5.384, p = .026, ηp2 = .124, Cohen’s d = 
0.753; low > high). Among the two-way interactions, those between treatment 
condition and gender (F(1,38) = 9.778, p = .003, ηp2 = .205, Cohen’s d = 1.016), and 
MT group and gender (F(1,38) = 5.221, p = .028, ηp2 = .121, Cohen’s d = 0.742) were 
significant. For the first interaction (treatment condition x gender), post hoc 
comparisons revealed a higher pain threshold score in the analgesia-expectation 
than in the control-expectation condition for boys (p = .003) and girls (p < .001, Fig. 
2). Moreover, in the analgesia-expectation condition, the pain threshold score 
increase was comparable for the two gender groups (p = .083) but there was a lower 
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threshold score in girls as compared to boys in the control-expectation group (p = 
.036) (Fig. 2). 
 
---------------------INSERT Fig. 2 ABOUT HERE-------------------- 
 
For the second interaction (MT group x gender), post hoc comparisons showed a 
marginally higher threshold score for boys in the low compared to the high MT group 
(p = .078), but no such difference for the girls (p = .869) (Fig. 3).  
 
---------------------INSERT Fig. 3 ABOUT HERE-------------------- 
 
3.4. Pain tolerance 
ANOVA for heat pain tolerance indicated a significant main effect for treatment 
condition (F(1,37) = 35.573, p < .001, ηp2 = .490, Cohen’s d = 1.960; analgesia > 
control) and for the covariate age (F(1,37) = 7.821, p = .008, ηp2 = .175, Cohen’s d = 
0.921; older > younger). Moreover, there was a significant interaction between 
treatment condition and forearm side (F(1,37) = 6.838, p = .013, ηp2 = .156, Cohen’s 
d = .860) (Fig. 4). Post-hoc t-test comparisons revealed a higher tolerance increase 
for participants in the analgesia-expectation than in the control-expectation condition 
on both forearm sides (p ≤ .001). Within both treatment conditions, tolerance scores 
between the right and left forearms were comparable (p ≥ .085).  
 
---------------------INSERT Fig. 4 ABOUT HERE------------------- 
 
In addition, there was a significant interaction between MT group and forearm side  
(F(1,37) = 7.461, p = .010, ηp2 = .168, Cohen’s d = 0.899) (Fig. 5A). Post-hoc t-test 
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comparisons revealed a higher tolerance score for the right than the left forearm side 
in the low MT group (p = .016), but no difference in the tolerance score between 
forearm sites in the high MT group (p = .170). For both forearms there were no MT 
group differences in the tolerance score (p ≥ .169). 
  
---------------------INSERT Fig. 5 ABOUT HERE-------------------- 
 
Finally, this interaction was also dependent on the factor gender since there was a 
three-way interaction between MT group, forearm side, and gender group (F(1,37) = 
5.392, p = .026, ηp2 = .127, Cohen’s d = 0.763). As shown in figures 5B and 5C, side 
and MT group differences were evident in boys (Fig. 5B) but absent in girls (p ≥ .228) 
(Fig. 5C): Post-hoc t-test comparisons revealed a higher tolerance score for the right 
than the left forearm side in the low MT group (p = .031). In addition, boys in the high 
MT group showed a tolerance increase on the left, but a decrease on the right side (p 
= .021). Moreover, MT group differences were absent for the left forearm (p = .936) 
but found for the right forearm-side (p = .021): while low MT children showed an 
increase, high MT children demonstrated a decrease in heat pain tolerance.  
3.5. Subjective pain intensity and pain unpleasantness judgments 
Non-parametric analyses of pain ratings did not show any significant group 
differences for pain intensity ratings (p ≥ .10) or for pain unpleasantness ratings (p ≥ 
.06). 
3.6. Subjective reports 
Perceived treatment efficacy: Chi-square analyses revealed that there was a 
significant association between the perceived treatment efficacy and treatment 
condition (χ2(3) = 36.76, p < .01), but no significant association between perceived 
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treatment efficacy and MT group (χ2(3) = .38, p = .94) as well as between perceived 
treatment efficacy and gender (χ2(3) = 1.83, p = .61). 
Experimenter likeability: Chi-square analyses revealed that there were no significant 
associations between likeability and treatment condition (χ2(2) = .07, p = .97), 
between likeability and MT group (χ2(2) = 1.02, p = .60) and between likeability and 
gender (χ2(2) = 5.04, p = .08). 
4. Discussion  
 
Short and long-term beliefs modulate placebo analgesia. Despite the recent 
tremendous strides in placebo research, the effects of analgesia expectations have 
never been experimentally tested in healthy children.  
Our results clearly indicate that heat pain perception in children is a complex 
psychological state that is mediated by context-induced short-term expectancies for 
analgesia, as well as long-term beliefs, such as magical thinking.  Our results also 
suggest that the effects of expectancies and magical thinking on placebo analgesia in 
children are influenced in complex ways by gender and laterality (i.e., right vs. left 
forearms). 
 
4.1. Placebo Analgesia Responses  
In line with our first hypothesis, children exposed to the “analgesia-expectation” 
condition via a single verbal suggestion with a strong metaphorical character 
demonstrated a substantial PA response, expressed by a significant increase of heat 
pain tolerance and threshold on both forearm sides. Moreover, the analgesia 
expectancy effect for heat pain threshold was greater for girls than for boys. All 
associated subjective pain ratings were uninfluenced by any of these factors.  
Krummenacher et al., 2014 
 17
It has been suggested that children and adolescents generally show larger PR 
than adults (6, 8). Our experimental approach clearly confirms this age effect. The 
difference scores between baseline and post-treatment in the analgesia-expectation 
group were 5.6-times higher than those found in a healthy adult population with 
regard to heat pain tolerance and 3.6-times higher with regard to heat pain threshold 
using a similar paradigm (12). Several psychological and neurodevelopmental 
reasons may account for the larger PR in children. First, children may be 
predisposed to larger PR due to their higher suggestibility (6). Suggestibility changes 
over the processes of neurodevelopment (43) and has been shown to increase 
steadily from an early age, to peak between 9 and 12 years, and to decline thereafter 
(44). Moreover, conceptualizing placebo processes as learning phenomena (45), 
children may show higher PR due to their possible facilitated learning capacities, 
openness to new experiences and learning motivation (46). Also, Parellada et al. 
(2002) pointed out that children’s framing and belief system might be not yet 
modulated by experience as it is in adults (6). Similarly, their prediction and prejudice 
system is not yet shaped by learning. An experimenter or “parents” bias in the 
present findings is not a likely factor for the reason that (1) all children were tested 
individually without the parents, (2) children were visually shielded from the 
experimenter during the pain assessment, and (3) experimenter and study likability – 
assessed via systemic indirect circular questions – were not judged differently across 
the treatment conditions. Finally, the larger PR may also relate to differences in 
placebo interventions. Indeed, hero role playing induced modulation of self-
perception has been demonstrated to increase heat pain tolerance in healthy adults 
(47).  
Expectations of analgesia induced by verbal suggestions that anticipate a 
benefit have repeatedly been demonstrated to be one of the pivotal initiators and 
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modulators of PR (13). Different psychological mechanism such as activation of 
reward processes (48, 49), reframing (50), decline of self-defeating thoughts (51), 
motivational gain (52) and anxiety reduction (53) have been considered to explain 
these positive health-coupled changes in the mind-brain body unit. However, for the 
present results anxiety reduction seems to be an unlikely explanation since – despite 
the fact that higher trait anxiety scores were associated with lower heat pain 
threshold scores – state anxiety difference scores were comparable in both treatment 
conditions.  
 Our behavioral data only allows for speculation about possible neural 
underpinnings. From a neurobiological point of view, the PFC (12, 13) and its 
connectivity with the rest of the brain (54) has been repeatedly demonstrated to be of 
critical importance in the top-down, expectation-mediated model of adult placebo 
responses. In children, the PFC does not reach maturity and full connectivity until at 
least adolescence, and possibly not even until early adulthood (16, 17, 55). Indeed, 
there are significant structural and functional differences between adults and children 
(16). Especially the increasing connectivity and changing balance between dynamic 
interacting later-maturing high association frontal lobe cortical networks (56) and 
earlier-maturing subcortical limbic systems in pediatrics. Moreover, patterns of 
cortical activation during cognitive tasks such as word generation (57), response 
inhibition (58) and selective attention (59) have been reported to be more diffuse in 
children and to rely more on subcortical brain network activation (60). Therefore, 
expectation-related PA in children suggests alternative – probably more subcortical – 
neural pathways and processing strategies. As contrasted with a more cognitively-
mediated PA in adults, one might speculate that in children, reward-related 
motivational, emotional appraisal (e.g. safety) and associated changes in intra-
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subcortical limbic-related circuitries (61), as well as  attachment are critical for the 
mediation of PA. 
 
4.2. Gender-dependent differences in PA 
The PR for heat pain threshold was stronger for girls compared to boys as threshold 
difference scores increased more strongly between controls and the analgesia-
expectation group in girls than boys. The literature regarding gender difference of PR 
is sparse and equivocal (62), and analyses of gender-specific PR in the pediatric 
population have been especially neglected (8). Whereas some reviews failed to find 
differences (63) others have reported a slight placebo susceptibility advantage for 
girls in a migraine headache review (64). In the adult population, several factors such 
as differences in stress level, cortical processing styles, type of the placebo learning 
paradigm, hormonal influences, reporting biases, or the gender of the experimenter 
have been proposed as explanations for gender differences (62). Our results suggest 
mechanisms other than hormonal influences such as a possible slightly higher 
suggestibility for girls (65) (but see (66)), not attributable to differences in receptive 
language skills (66).  
 
4.3. MT modulates pain processing in boys, but not PA 
The findings both defy and confirm our original hypotheses. Against our prediction, 
PA was not influenced by MT. Previous findings (21) in healthy adults suggested a 
larger susceptibility for high MT participants. Several reasons may account for our 
failed replication. First, pronounced MT is a healthy property of a child's thinking (22, 
23), and not an indicator of subclinical psychotic development (67). Therefore, 
quantitative and qualitative differences in youngsters' vs. adults' MT may hamper 
direct comparison with previous studies. Likewise, the fact that suggestibility is 
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already extremely high at around 12 years of age (68) may have blurred 
hypothesized MT related suggestibility differences due to a ceiling effect. Lastly, 
differences in the type of pain stimuli and the absence of a control group without a 
placebo intervention in the study design of (21) might have produced these 
inconsistencies.  
In line with our hypothesis, pain perception was asymmetrically modulated by 
MT. In the group with low MT, pain tolerance was higher for the right than the left 
forearm. Surprisingly no side difference was observed in the high MT group. This 
modulation is an exact replication of the pattern that has recently been reported in a 
similar study with healthy men (21). The result suggests an association between MT 
and a heightened right hemispheric activity already in children. A general bias 
towards right-hemisphere processing has long been described in infants and children 
(69), but our findings suggest that it may be modulated by gender as much as it is in 
adults (70). As gender-specific hormonal influences on dynamic functional laterality 
(71) and pain perception (72) is not a probable candidate to account for the 
interactions between laterality, MT and gender, future research is clearly needed to 
explore these fascinating, yet confusing interplay more thoroughly. 
 
4.4. Limitations, implications and future studies 
Undoubtedly, our study findings require replication in larger samples, and the 
underlying neural mechanisms of expectation-induced PA in relation to this dynamic 
nature of brain and cognitive-emotional development in children need to be 
unraveled. Of special interest would be the comparison between different cognitive 
and motivational neurodevelopment-related maturity and connectivity phases 
combined with a specific focus on the interaction between subcortical and prefrontal 
cortices. In addition, given that in our study heat pain threshold was difficult to assess 
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reliably, more intuitive, real-time and non-verbal language measurement tools such 
as the recently proposed “pain mouse” (73) could be implemented in future pain 
assessment designs.  
Clearly, the generalizability and potential implications to clinical practice of our 
data is limited since our study was designed to investigate the role of experimentally 
induced PA in acute and controllable thermal pain. Also, our present data does not 
enable a disentangling of differential components of the placebo intervention such as 
the narrative expectancy-induction, the disinfectant, its color and appearance or the 
warm relationship with the experimenter. Future studies may compare different types 
of verbal/nonverbal and conscious/unconscious suggestions (74) as well as the use 
other learning paradigms such as associative learning and learning by observation 
(75) and imitation.  
 
In conclusion, the present study provides the first experimental evidence for a 
considerable expectation-related PA response on pain threshold and tolerance in 
healthy children. In addition, independent of analgesia expectations, MT modulated 
pain tolerance exclusively in male children. Overall this research suggests that 
context induced short-term analgesia beliefs and long-term MT beliefs independently 
modulate the experience of pain. These findings challenge the simple view of 
interpolating adult findings to the pediatric population. An improved understanding of 
the interaction between subjective belief and meaning systems, gender and age-
related neurodevelopmental phases in pain processing might have the potential to 
enhance therapeutic outcomes in children’s individualized pain management. 
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Figure Captions 
 
 
Fig. 1. Experimental design. Half of the children were either randomly – stratified for 
magical thinking (MT) and gender – assigned to the analgesia-expectation (“blue 
hand disinfectant as painkiller”, upper panel) or a control-expectation condition (“blue 
hand disinfectant as measurement facilitator”, lower panel). Children’ heat pain 
tolerance and threshold as well as subjective pain judgments by means of FPS-R 
(Faces Pain Scale-Revised) and FAS (Facial Affective Scale) were measured on 
both volar forearms (counterbalanced and homologous site) at baseline and after the 
expectation induction procedure. Participants’ state anxiety was assessed prior to 
each of the two pain measurements. Trait anxiety was judged at the end of the 
experiment. 
 
Fig. 2: Difference score (treatment condition – baseline condition) of heat pain 
threshold (mean ± SEM) for girls (white bars) and boys (grey bars) in both 
expectation conditions (‘‘control-expectation” or ‘‘analgesia-expectation”). Baseline 
level = 0; placebo analgesia = positive values. Asterisks (*,**,***) indicate significant 
post-hoc and baseline comparisons (*p < 0.05; **p < 0.01; ***p < 0.001). Data are 
averaged over MT group (low and high MT) and side of pain application (left and right 
forearm).  
 
Fig. 3: Difference score (treatment condition – baseline condition) of heat pain 
threshold (mean ± SEM) for both MT groups (‘‘low MT” or ‘‘high MT”) in girls (white 
bars) and boys (grey bars). Baseline level = 0; placebo analgesia = positive values. 
Asterisks (*,**,***) indicate significant post-hoc and baseline comparisons (*p < 0.05; 
**p < 0.01; ***p < 0.001). Data are averaged over expectation condition (control-
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expectation and analgesia-expectation) and side of pain application (left and right 
forearm).  
 
Fig. 4: Difference score (treatment condition – baseline condition) of heat pain 
tolerance (mean ± SEM) for left (white bars) and right (grey bars) forearm heat pain 
stimulation in both expectation conditions (‘‘control-expectation” or ‘‘analgesia-
expectation”). Baseline level = 0; placebo analgesia = positive values. Asterisks 
(*,**,***) indicate significant post-hoc and baseline comparisons (*p < 0.05; **p < 
0.01; ***p < 0.001). Data are averaged over MT group (low and high MT) and gender 
(girls and boys). 
 
Fig. 5: Difference score (treatment condition – baseline condition) of heat pain 
tolerance (mean ± SEM) for left (white bars) and right (grey bars) forearm heat pain 
stimulation in both MT groups (‘‘low MT” or ‘‘high MT”) (A) and separated for girls (B) 
and boys (C). Baseline level = 0; placebo analgesia = positive values. Asterisks 
(*,**,***) indicate significant post-hoc and baseline comparisons (*p < 0.05; **p < 
0.01; ***p < 0.001). Data are averaged over expectation condition (control-
expectation and analgesia-expectation) and gender (girls and boys) (A) and only over 
expectation condition (control-expectation and analgesia-expectation) (B, C). 
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Table Legend 
 
Table 1: Descriptive data of the study sample.  
Data (Means (SD)) correspond to the two treatment conditions (analgesia-
expectation or control-expectation) and the four corresponding subgroups (low and 
high magical thinking in boys and girls). 
 
 
 
